The diagnostic value of the expression levels of KLRG1, BTK, CCR2 and SCML4 in LUADs was studied by analyzing the expression data from 483 LUADs and 347 normal tissues. Specificity and sensitivity were plotted on the x- and y-axes, respectively. The area under curve (AUC) was calculated to assess the ability of the expression levels of KLRG1, BTK, CCR2 and SCML4 to predict the outcome of patients with LUAD.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.